Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai

Translated title of the contribution: One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons

Kiss Attila, Reményi Gyula, Szász Róbert, Batár Péter, Rejto László, Váróczy László, Sípos Tamás, Kovácsné Kovács Erika, Szarvas Marianna, M. Udvardy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Five years ago (in September, 2003), the activity of the 5th Haemopoietic Stem Cell Transplantation Centre of Hungary has begun. This centre has been registered as No 648. by the European Group for Blood and Marrow Transplantation-Centres. Aims: To supply the needs of stem cell transplantation regions in north-east Hungary and to develop an active co-operation with the Hungarian and international centres. Methods: Transplantations were made according to international criteria. Results: 150 autologous stem cell transplantations has been performed so far, including 74 patients with myeloma multiplex, 43 patients with non-Hodgkin lymphoma, 27 patients with Hodgkin's disease, 4 patients with autoimmune disease, and one patient with leiomyosarcoma. The survival rates were similar to the previous Hungarian and international data. The centre played a role in other activities using stem cell therapy at the University of Debrecen (dendritic cell vaccina program, stem cell therapy in myocardial infarction, stem cell therapy in peripheral arterial- and autoimmune diseases). This centre performed the largest quantity of the conditioningprotocol Zevalin, Bischloronitrosourea, Etopozid, cytosin-Arabinosid, Melphalan in non-Hodgkin lymphoma in Hungary; ten patients were treated with this protocol.

Original languageHungarian
Pages (from-to)1251-1257
Number of pages7
JournalOrvosi Hetilap
Volume150
Issue number27
DOIs
Publication statusPublished - Jul 1 2009

Fingerprint

Peripheral Blood Stem Cell Transplantation
Hungary
Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Stem Cells
Non-Hodgkin's Lymphoma
Autoimmune Diseases
Melphalan
Leiomyosarcoma
Peripheral Arterial Disease
Hodgkin Disease
Dendritic Cells
Survival Rate
Transplantation
Myocardial Infarction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Attila, K., Gyula, R., Róbert, S., Péter, B., László, R., László, V., ... Udvardy, M. (2009). Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai. Orvosi Hetilap, 150(27), 1251-1257. https://doi.org/10.1556/OH.2009.28557

Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai. / Attila, Kiss; Gyula, Reményi; Róbert, Szász; Péter, Batár; László, Rejto; László, Váróczy; Tamás, Sípos; Erika, Kovácsné Kovács; Marianna, Szarvas; Udvardy, M.

In: Orvosi Hetilap, Vol. 150, No. 27, 01.07.2009, p. 1251-1257.

Research output: Contribution to journalArticle

Attila, K, Gyula, R, Róbert, S, Péter, B, László, R, László, V, Tamás, S, Erika, KK, Marianna, S & Udvardy, M 2009, 'Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai', Orvosi Hetilap, vol. 150, no. 27, pp. 1251-1257. https://doi.org/10.1556/OH.2009.28557
Attila K, Gyula R, Róbert S, Péter B, László R, László V et al. Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai. Orvosi Hetilap. 2009 Jul 1;150(27):1251-1257. https://doi.org/10.1556/OH.2009.28557
Attila, Kiss ; Gyula, Reményi ; Róbert, Szász ; Péter, Batár ; László, Rejto ; László, Váróczy ; Tamás, Sípos ; Erika, Kovácsné Kovács ; Marianna, Szarvas ; Udvardy, M. / Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai. In: Orvosi Hetilap. 2009 ; Vol. 150, No. 27. pp. 1251-1257.
@article{5e7776b7165149d888119b560280cdee,
title = "Sz{\'a}z{\"o}tven autol{\'o}g perif{\'e}ri{\'a}s haemopoeticus o ssejt transzplant{\'a}ci{\'o} {\'e}s tanuls{\'a}gai",
abstract = "Five years ago (in September, 2003), the activity of the 5th Haemopoietic Stem Cell Transplantation Centre of Hungary has begun. This centre has been registered as No 648. by the European Group for Blood and Marrow Transplantation-Centres. Aims: To supply the needs of stem cell transplantation regions in north-east Hungary and to develop an active co-operation with the Hungarian and international centres. Methods: Transplantations were made according to international criteria. Results: 150 autologous stem cell transplantations has been performed so far, including 74 patients with myeloma multiplex, 43 patients with non-Hodgkin lymphoma, 27 patients with Hodgkin's disease, 4 patients with autoimmune disease, and one patient with leiomyosarcoma. The survival rates were similar to the previous Hungarian and international data. The centre played a role in other activities using stem cell therapy at the University of Debrecen (dendritic cell vaccina program, stem cell therapy in myocardial infarction, stem cell therapy in peripheral arterial- and autoimmune diseases). This centre performed the largest quantity of the conditioningprotocol Zevalin, Bischloronitrosourea, Etopozid, cytosin-Arabinosid, Melphalan in non-Hodgkin lymphoma in Hungary; ten patients were treated with this protocol.",
keywords = "Autologous, Conditioning, Haemopoietic, Harvesting, Remission, Stem cell, Survival-probability, Transplantation",
author = "Kiss Attila and Rem{\'e}nyi Gyula and Sz{\'a}sz R{\'o}bert and Bat{\'a}r P{\'e}ter and Rejto L{\'a}szl{\'o} and V{\'a}r{\'o}czy L{\'a}szl{\'o} and S{\'i}pos Tam{\'a}s and Erika, {Kov{\'a}csn{\'e} Kov{\'a}cs} and Szarvas Marianna and M. Udvardy",
year = "2009",
month = "7",
day = "1",
doi = "10.1556/OH.2009.28557",
language = "Hungarian",
volume = "150",
pages = "1251--1257",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "27",

}

TY - JOUR

T1 - Százötven autológ perifériás haemopoeticus o ssejt transzplantáció és tanulságai

AU - Attila, Kiss

AU - Gyula, Reményi

AU - Róbert, Szász

AU - Péter, Batár

AU - László, Rejto

AU - László, Váróczy

AU - Tamás, Sípos

AU - Erika, Kovácsné Kovács

AU - Marianna, Szarvas

AU - Udvardy, M.

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Five years ago (in September, 2003), the activity of the 5th Haemopoietic Stem Cell Transplantation Centre of Hungary has begun. This centre has been registered as No 648. by the European Group for Blood and Marrow Transplantation-Centres. Aims: To supply the needs of stem cell transplantation regions in north-east Hungary and to develop an active co-operation with the Hungarian and international centres. Methods: Transplantations were made according to international criteria. Results: 150 autologous stem cell transplantations has been performed so far, including 74 patients with myeloma multiplex, 43 patients with non-Hodgkin lymphoma, 27 patients with Hodgkin's disease, 4 patients with autoimmune disease, and one patient with leiomyosarcoma. The survival rates were similar to the previous Hungarian and international data. The centre played a role in other activities using stem cell therapy at the University of Debrecen (dendritic cell vaccina program, stem cell therapy in myocardial infarction, stem cell therapy in peripheral arterial- and autoimmune diseases). This centre performed the largest quantity of the conditioningprotocol Zevalin, Bischloronitrosourea, Etopozid, cytosin-Arabinosid, Melphalan in non-Hodgkin lymphoma in Hungary; ten patients were treated with this protocol.

AB - Five years ago (in September, 2003), the activity of the 5th Haemopoietic Stem Cell Transplantation Centre of Hungary has begun. This centre has been registered as No 648. by the European Group for Blood and Marrow Transplantation-Centres. Aims: To supply the needs of stem cell transplantation regions in north-east Hungary and to develop an active co-operation with the Hungarian and international centres. Methods: Transplantations were made according to international criteria. Results: 150 autologous stem cell transplantations has been performed so far, including 74 patients with myeloma multiplex, 43 patients with non-Hodgkin lymphoma, 27 patients with Hodgkin's disease, 4 patients with autoimmune disease, and one patient with leiomyosarcoma. The survival rates were similar to the previous Hungarian and international data. The centre played a role in other activities using stem cell therapy at the University of Debrecen (dendritic cell vaccina program, stem cell therapy in myocardial infarction, stem cell therapy in peripheral arterial- and autoimmune diseases). This centre performed the largest quantity of the conditioningprotocol Zevalin, Bischloronitrosourea, Etopozid, cytosin-Arabinosid, Melphalan in non-Hodgkin lymphoma in Hungary; ten patients were treated with this protocol.

KW - Autologous

KW - Conditioning

KW - Haemopoietic

KW - Harvesting

KW - Remission

KW - Stem cell

KW - Survival-probability

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=67650323718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650323718&partnerID=8YFLogxK

U2 - 10.1556/OH.2009.28557

DO - 10.1556/OH.2009.28557

M3 - Article

C2 - 19531458

AN - SCOPUS:67650323718

VL - 150

SP - 1251

EP - 1257

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 27

ER -